NextCure  company info

What does NextCure  do?
NextCure (NASDAQ:NXTC) is a biotechnology company focused on discovering and developing novel immunotherapies for cancer and other immune-related diseases. By leveraging its proprietary FIND-IO™ platform, NextCure aims to identify and advance therapeutic proteins and peptides that harness the body's immune system to fight disease effectively. The company's pipeline of projects includes several promising candidates in different stages of development, aimed at addressing unmet medical needs across various oncological indications. With a commitment to innovation and patient welfare, NextCure's objective is to push the boundaries of scientific research to provide new, effective treatments that improve patient outcomes and quality of life.
NextCure  company media
Company Snapshot

Is NextCure  a public or private company?

key
Ownership
Public

How many people does NextCure  employ?

people
Employees
82

What sector is NextCure  in?

pie chart
Sector
Health Care

Where is the head office for NextCure ?

location pin
Head Office
Maryland, United States

What year was NextCure  founded?

founded flag
Year Founded
2015
What does NextCure  specialise in?
/Cancer Therapeutics /Immunomedicine Platform /Clinical Trials /Drug Development /Discovery Research /Biomarker Technology

What are the products and/or services of NextCure ?

Overview of NextCure  offerings
NC318, an immunomedicine targeting Siglec-15, aimed at enhancing immune system's ability to fight cancer.
NC410, a novel immune modulator designed to restore immune recognition and kill cancer cells.
NC762, a monoclonal antibody that targets B7-H4, potentially inhibiting tumor growth.
Collaboration with Yale University to identify novel cancer targets, leveraging NextCure's FIND-IO platform.

Who is in the executive team of NextCure ?

NextCure  leadership team
  • Mr. Michael S. Richman MSBA
    Mr. Michael S. Richman MSBA
    Co-Founder, CEO, President & Director
  • Dr. Solomon  Langermann Ph.D.
    Dr. Solomon Langermann Ph.D.
    Chief Scientific Officer
  • Dr. Han  Myint FACP, M.D.
    Dr. Han Myint FACP, M.D.
    Chief Medical Officer
  • Dr. Lieping  Chen M.D., Ph.D.
    Dr. Lieping Chen M.D., Ph.D.
    Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Steven P. Cobourn CPA
    Mr. Steven P. Cobourn CPA
    Chief Financial Officer
  • Dr. Timothy  Mayer Ph.D.
    Dr. Timothy Mayer Ph.D.
    Chief Operating Officer
  • Mr. Kevin G. Shaw
    Mr. Kevin G. Shaw
    General Counsel
  • Ms. Stacy  Rollinger
    Ms. Stacy Rollinger
    Vice President of Human Resources